The Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund announce a publication…
Read More
Sputnik V demonstrates 97% efficacy against hospitalisation caused by Omicron variant following revaccination with Sputnik Light or Sputnik V according to a study published in the Vaccines peer-reviewed leading medical journal,,
The Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) today announced that Vaccines, the leading peer-reviewed medical journal,…
Read More
Healthcare startup Mykare has registered more than 300% revenue growth since July 2020
Mykare a tech-enabled full-stack asset-light and bootstrapped healthcare startup has registered a growth of more than 300% in its revenue…
Read MoreChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron
Avifavir® is effective against various variants of coronavirus, including Delta and Omicron, as it affects the highly conservative and mutation-resistant…
Read More
